Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03715036 · ClinicalTrials.gov registry record · NA
Point of Care Ultrasound Screening for Abnormal Fetal Growth During Routine Antenatal Visits
A NA study, sponsored by The University of Texas Medical Branch, Galveston.
- Completed
- Registry status
- NA
- Development phase
- 177
- Enrollment target
NCT03715036: Completed NA study, sponsored by The University of Texas Medical Branch, Galveston.
NCT03715036 is a NA study that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 177 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03715036, a NA study, has completed, sponsored by The University of Texas Medical Branch, Galveston.
- COMPLETED
- Registry status
- NA
- Development phase
- 177 participants
- Enrollment target
Study Summary
Abdominal circumference (AC) in the fetus is the single most useful indicator of fetal growth abnormalities. Measurement of AC as well as DVP do not require extensive training. Our objective is to evaluate if introduction of bedside ultrasound during routine antenatal visits to evaluate fetal AC and amniotic fluid DVP would decrease the false positive rates of fundal height measurement in diagnosing intrauterine growth abnormalities.
Primary Outcome
To compare the false positive rates between clinical evaluation of uterine size by SFH versus POC-US evaluation of AC and DVP.
Interventions
- DIAGNOSTIC_TEST Point-of-care US
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 177 participants |
| Start Date | 2019-04-29 |
| Est. Completion | 2020-03-30 |
| Phase | NA |
What the finished NCT03715036 record still lists
NCT03715036 is an interventional study that assigns participants to a tested intervention. The registered 177 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 1 intervention - of which Point-of-care US is the first listed.
NCT03715036 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03715036 about?
NCT03715036 is a clinical study titled "Point of Care Ultrasound Screening for Abnormal Fetal Growth During Routine Antenatal Visits". Abdominal circumference (AC) in the fetus is the single most useful indicator of fetal growth abnormalities. Measurement of AC as well as DVP do not require extensive training. Our objective is to evaluate if introduction of bedside ultrasound during routine antenatal visits to evaluate fetal AC and...
What is the current status of trial NCT03715036?
This trial is currently completed. It is a NA study. The enrollment target is 177 participants. The study started on 2019-04-29. Estimated completion is 2020-03-30.
What interventions are being tested in trial NCT03715036?
The interventions under investigation include: Point-of-care US (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03715036?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03715036's enrollment target sits among peer trials
177 604th of 2000 higher than 1,396 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05491551 · 177 participants · NA
Alcohol-ROC-Training
- NCT06108050 · 177 participants · Phase 1
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
- NCT06575712 · 177 participants · NA
Coping Skills Training for Symptom Management and Daily Steps (Step Up)
- NCT06674980 · 177 participants · NA
Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI